EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82-Reference-Cited by-同舟云学术

EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82

Published:2015-07 Issue:7 Volume:1852 Page:1540-1549
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Yang Chi-Hwa,Chou Hsiao-Chin,Fu Yu-Ning,Yeh Chi-Ling,Cheng Hui-Wen,Chang Il-Chi,Liu Ko-Jiunn,Chang Gee-Chen,Tsai Ting-Fen,Tsai Shih-Feng,Liu Hui-Ping,Wu Yi-Cheng,Chen Ya-Ting,Huang Shiu-Feng,Chen Yi-Rong

Funder

National Science Council

National Health Research Institutes

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference40 articles.

1. EGF–ErbB signalling: towards the systems level;Citri;Nat. Rev. Mol. Cell Biol.,2006

2. The ErbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors;Rowinsky;Annu. Rev. Med.,2004

3. High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancer related to gefitinib responsiveness in Taiwan;Huang;Clin. Cancer Res.,2004

4. Mutations of the epidermal growth factor gene in lung cancer: biological and clinical implications;Kosaka;Cancer Res.,2004

5. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro and In Silico Evaluation of 2-(1H-Benzo[d]imidazol-2-yl)-3-(4-(piperazin-1-yl)phenyl)propanenitrile as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors;Russian Journal of Bioorganic Chemistry;2024-08

2. DUSP22 inhibits lung tumorigenesis by suppression of EGFR/c-Met signaling;Cell Death Discovery;2024-06-14

3. Ciprofloxacin and Norfloxacin Hybrid Compounds: Potential Anticancer Agents;Current Topics in Medicinal Chemistry;2024-03

4. Co-delivery of PD-L1- and EGFR-targeting siRNAs by synthetic PEG12-KL4 peptide to the lungs as potential strategy against non-small cell lung cancer;European Journal of Pharmaceutics and Biopharmaceutics;2024-02

5. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review;Critical Reviews in Oncology/Hematology;2024-02